Cytotoxic agents for the treatment of cancer
US10278981B2 · kind B2 · utility
1Cited by
6References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 4, 2014 |
| Grant date | May 7, 2019 |
| Priority date | — |
| Expiry date | Jun 4, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of treating brain cancer comprising administering a therapeutically effective substance to a patient, wherein the therapeutically effective substance comprises: (I), or a pharmaceutically acceptable salt thereof, wherein X is a. moiety that can be cleaved hydrolytically or enzymatically in the body of the patient in a pH-dependent manner.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.